insurance; prostate cancer; cost sharing

HB 2617 prohibits health insurers in Arizona from requiring cost-sharing (like copays or deductibles) for diagnostic prostate cancer screenings for specific high-risk men starting January 1, 2027. It directly affects men who are 55 or older, carry BRCA1/BRCA2 genetic mutations, have a family history of prostate cancer (including first-degree relatives diagnosed or deceased from it), or are military veterans exposed to Agent Orange. The bill applies to hospital service corporations, health care organizations, disability insurers, and group disability insurers. Key provisions define "high-risk" categories and mandate coverage without cost-sharing for screenings, aiming to improve early detection access for these groups. The law does not change screening guidelines but removes financial barriers for covered services.